Fractalkine preferentially mediates arrest and migration of CD16+ monocytes

Journal of Experimental Medicine

Volumn 197, Issue 12, 2003, Pages 1701-1707

  Ancuta, Petronela ^a   Rao, Ravi ^b   Moses, Ashlee ^c   Mehle, Andrew ^a   Shaw, Sunil K ^b   Luscinskas, F William ^b   Gabuzda, Dana ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cell adhesion; Chemokine receptors; Chemokines; Chemotaxis; Inflammation

Indexed keywords

ALPHA INTERFERON; CD14 ANTIGEN; CD16 ANTIGEN; CD33 ANTIGEN; CD56 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; FRACTALKINE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL INJURY; CELL ADHESION; CELL MIGRATION; CELL SURFACE; CELL TRANSPORT; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANTIBODIES, MONOCLONAL; CELL CYCLE; CELL MOVEMENT; CHEMOKINES, CX3C; HUMANS; LYMPHOCYTE SUBSETS; MEMBRANE PROTEINS; MONOCYTES; PHENOTYPE; PROTEIN BINDING; RECEPTORS, CHEMOKINE; RECEPTORS, IGG;

EID: 0037867044     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20022156     Document Type: Article

References (30)

1. Grage-Griebenow, E., H.D. Flad, and M. Ernst. 2001. Heterogeneity of human peripheral blood monocyte subsets. J. Leukoc. Biol. 69:11-20.
2. + subpopulation. Immunol. Today. 17:424-428.
3. high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 25:3418-3424.
4. Pulliam, L., R. Gascon, M. Stubblebine, D. McGuire, and M.S. McGrath. 1997. Unique monocyte subset in patients with AIDS dementia. Lancet. 349:692-695.
5. ++ monocytes are a major source of TNF. J. Immunol. 168:3536-3542.
6. +) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 196:517-527.
7. Weber, C., K.U. Belge, P. von Hundelshausen, G. Draude, B. Steppich, M. Mack, M. Frankenberger, K.S. Weber, and H.W. Ziegler-Heitbrock. 2000. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67:699-704.
8. Kishimoto, T.K., M.A. Jutila, and E.C. Butcher. 1990. Identification of a human peripheral lymph node homing receptor: a rapidly down-regulated adhesion molecule. Proc. Natl. Acad. Sci. USA. 87:2244-2248.
9. + monocytes by exercise. Am. J. Physiol. Cell Physiol. 279:C578-C586.
10. Muller, W.A. 2001. New mechanisms and pathways for monocyte recruitment. J. Exp. Med. 194:47-51.
11. Palframan, R.T., S. Jung, G. Cheng, W. Weninger, Y. Luo, M. Dorf, D.R. Littman, B.J. Rollins, H. Zweerink, A. Rot, et al. 2001. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194:1361-1373.
12. Kurth, I., K. Willimann, P. Schaerli, T. Hunziker, I. Clark-Lewis, and B. Moser. 2001. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med. 194:855-861.
13. Janatpour, M.J., S. Hudak, M. Sathe, J.D. Sedgwick, and L.M. McEvoy. 2001. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J. Exp. Med. 194:1375-1384.
14. Kunkel, E.J., and E.C. Butcher. 2002. Chemokines and the tissue-specific migration of lymphocytes. Immunity. 16:1-4.
15. Moses, A.V., K.N. Fish, R. Ruhl, P.P. Smith, J.G. Strussenberg, L. Zhu, B. Chandran, and J.A. Nelson. 1999. Long-term infection and transformation of dermal microvascular endothelial cells by human herpes virus 8. J. Virol. 73:6892-6902.
16. Shaw, S.K., B.N. Perkins, Y.C. Lim, Y. Liu, A. Nusrat, F.J. Schnell, C.A. Parkos, and F.W. Luscinskas. 2001. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma does not reduce leukocyte transmigration under flow. Am. J. Pathol. 159:2281-2291.
17. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T.J. Schall, et al. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 91:521-530.
18. Luscinskas, F.W., H. Ding, P. Tan, D. Cumming, T.F. Tedder, and M.E. Gerritsen. 1996. L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-α-activated vascular endothelium under flow in vitro. J. Immunol. 157:326-335.
19. Perussia, B., and J.V. Ravetch. 1991. FcγRIII (CD16) on human macrophages is a functional product of the FcγRIII-2 gene. Eur. J. Immunol. 21:425-429.
20. Umehara, H., E. Bloom, T. Okazaki, N. Domae, and T. Imai. 2001. Fractalkine and vascular injury. Trends Immunol. 22:602-607.
21. Kubes, P. 2002. Introduction: the complexities of leukocyte recruitment. Semin. Immunol. 14:65-72.
22. Langford, D., V.J. Sanders, M. Mallory, M. Kaul, and E. Masliah. 2002. Expression of stromal cell-derived factor-1α protein in HIV encephalitis. J. Neuroimmunol. 127:115-126.
23. Bazan, J.F., K.B. Bacon, G. Hardiman, W. Wang, K. Soo, D. Rossi, D.R. Greaves, A. Zlotnik, and T.J. Schall. 1997. A new class of membrane-bound chemokine with a CX3C motif. Nature. 385:640-644.
24. Luscinskas, F.W., Y.C. Lim, and A.H. Lichtman. 2001. Wall shear stress: the missing step for T cell transmigration? Nat. Immunol. 2:478-480.
25. Fong, A.M., L.A. Robinson, D.A. Steeber, T.F. Tedder, O. Yoshie, T. Imai, and D.D. Patel. 1998. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188:1413-1419.
26. Jung, S., J. Aliberti, P. Graenunel, M.J. Sunshine, G.W. Kreutzberg, A. Sher, and D.R. Littman. 2000. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-4114.
27. Cook, D.N., S.C. Chen, L.M. Sullivan, D.J. Manfra, M.T. Wiekowski, D.M. Prosser, G. Vassileva, and S.A. Lira. 2001. Generation and analysis of mice lacking the chemokine fractalkine. Mol. Cell. Biol. 21:3159-3165.
28. -/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111:333-340.
29. Combadiere, C., S. Potteaux, J.L. Gao, B. Esposito, S. Casanova, E.J. Lee, P. Debre, A. Tedgui, P.M. Murphy, and Z. Mallat. 2003. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation. 107:1009-1016.
30. Pereira, C.F., J. Middel, G. Jansen, J. Verhoef, and H.S. Nottet. 2001. Enhanced expression of fractalkine in HIV-1 associated dementia. J. Neuroimmunol. 115:168-175.